Amazon India will cover the cost of COVID-19 vaccines for all its employees and associates

Amazon India announced on Monday that it would cover the cost of the COVID-19 vaccination for all its Indian employees and associates, including those working in its partner network ecosystem.

This includes delivery service partner associates, Amazon Flex drivers, ‘I Have Space’ store partners, trucking partners, and their eligible dependents. Sellers on with an active listing since 2020 will also be covered.

“As coronavirus vaccines become available to individuals above 45 years of age in India, Amazon India is encouraging its associates, employees, sellers on, and partners to get vaccinated at the earliest appropriate time to protect themselves, their families, and their communities,” the company said.

Amazon has set up comprehensive support mechanisms for its employees and associates and those hired through staffing agencies.
Amazon India will cover the cost for COVID-19 treatment, hospital search, and prescribed
COVID-19 test fees. The company has developed initiatives to address the current situation.

“These benefits are on top of the $2.5 billion Amazon invested in special bonuses and incentives for teams globally over the last year, and the $11.5 billion the company invested in coronavirus-related measures overall,” Amazon’s statement said.

The investment will enable Amazon India to provide its employees and partners with personal protective equipment (PPE) and extensive safety measures, in addition to other financial support initiatives.

A $25 million Amazon Relief Fund (ARF) was launched in India in April last year for Amazon’s partners. The fund continues to support all eligible individuals. The ARF can be used by eligible individuals who have been quarantined or diagnosed with COVID-19.

Several companies such as, Flipkart, Infosys, Cognizant, Capgemini, and others have also committed to covering the cost of COVID-19 vaccines for their employees and their family members.

People over the age of 60 and those above 45 years of age with comorbidities are being immunized in the second phase of the nation’s vaccine rollout program. Under the third phase, which commenced on April 1st, people above 45 are eligible for the vaccination.